Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Prostate Cancer

  Free Subscription


1 Cancer Lett
3 Eur Urol
3 J Nucl Med
1 Prog Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Cancer Lett

  1. LEE YG, Nam Y, Shin KJ, Yoon S, et al
    Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.
    Cancer Lett. 2019 Dec 12. pii: S0304-3835(19)30623.
    PubMed     Text format     Abstract available

    Eur Urol

  2. LI YR, Roach M 3rd
    Re: Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
    Eur Urol. 2019 Dec 12. pii: S0302-2838(19)30900.
    PubMed     Text format    

  3. RADZISZEWSKI P, Szablonski W
    Re: Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.
    Eur Urol. 2019 Dec 12. pii: S0302-2838(19)30902.
    PubMed     Text format    

  4. FROEHNER M, Koch R, Thomas C
    Re: Giorgio Gandaglia G, Peter Albers, Per-Anders Abrahamsson, et al. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol 2019;76:142-50.
    Eur Urol. 2020;77:e30.
    PubMed     Text format    

    J Nucl Med

  5. OH SW, Wurzer A, Teoh EJ, Oh S, et al
    Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of Novel Radiohybrid PSMA, (18)F- rhPSMA-7, in Patients with Prostate Cancer.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234609. doi: 10.2967/jnumed.119.234609.
    PubMed     Text format     Abstract available

  6. EIBER M, Kronke M, Wurzer A, Ulbrich L, et al
    (18)F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234914. doi: 10.2967/jnumed.119.234914.
    PubMed     Text format     Abstract available

  7. KRONKE M, Wurzer A, Schwamborn K, Ulbrich L, et al
    Histologically-confirmed diagnostic efficacy of (18)F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234906. doi: 10.2967/jnumed.119.234906.
    PubMed     Text format     Abstract available

    Prog Urol

  8. GAULLIER M, Tricard T, Garnon J, Cazzato RL, et al
    [Percutaneous MR-guided prostate cancer cryoablation: Predictive factors and oncologic outcomes].
    Prog Urol. 2019 Dec 11. pii: S1166-7087(19)30605.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.